Ontology type: schema:ScholarlyArticle Open Access: True
2017-08-04
AUTHORSYanyan Zhang, Erika Saavedra, Ruoping Tang, Yin Gu, Patrick Lappin, Dusko Trajkovic, Shu-Hui Liu, Tod Smeal, Valeria Fantin, Stephane De Botton, Ollivier Legrand, Francois Delhommeau, Flavia Pernasetti, Fawzia Louache
ABSTRACTThe chemokine receptor CXCR4 mediates cell anchorage in the bone marrow (BM) microenvironment and is overexpressed in 25–30% of patients with acute myeloid leukemia (AML). Here we have shown that a new CXCR4 receptor antagonist IgG1 antibody (PF-06747143) binds strongly to AML cell lines and to AML primary cells inhibiting their chemotaxis in response to CXCL12. PF-06747143 also induced cytotoxicity in AML cells via Fc-effector function. To characterize the effects of PF-06747143 on leukemia progression, we used two different patient-derived xenograft (PDX) models: Patient 17CXCR4-low and P15CXCR4-high models, characterized by relatively low and high CXCR4 expression, respectively. Weekly administration of PF-06747143 to leukemic mice significantly reduced leukemia development in both models. Secondary transplantation of BM cells from PF-06747143-treated or IgG1 control-treated animals showed that leukemic progenitors were also targeted by PF-06747143. Administration of a single dose of PF-06747143 to PDX models induced rapid malignant cell mobilization into the peripheral blood (PB). These findings support evaluation of this antibody in AML therapy, with particular appeal to patients resistant to chemotherapy and to unfit patients, unable to tolerate intensive chemotherapy. More... »
PAGES7305
http://scigraph.springernature.com/pub.10.1038/s41598-017-07848-8
DOIhttp://dx.doi.org/10.1038/s41598-017-07848-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1090990621
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/28779088
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibody-Dependent Cell Cytotoxicity",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents, Immunological",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Apoptosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Movement",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chemotaxis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Models, Animal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myeloid, Acute",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mice",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Molecular Targeted Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Primary Cell Culture",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, CXCR4",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Xenograft Model Antitumor Assays",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "CNRS, GDR 3697, MicroNIT, Villejuif, France",
"id": "http://www.grid.ac/institutes/grid.4444.0",
"name": [
"INSERM, UMR 1170, 114 rue Edouard Vaillant, 94805, Villejuif, France",
"Universit\u00e9 Paris-Saclay, Gustave Roussy, Villejuif, France",
"Gustave Roussy, 94805, Villejuif, France",
"CNRS, GDR 3697, MicroNIT, Villejuif, France"
],
"type": "Organization"
},
"familyName": "Zhang",
"givenName": "Yanyan",
"id": "sg:person.0701756766.16",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701756766.16"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CNRS, GDR 3697, MicroNIT, Villejuif, France",
"id": "http://www.grid.ac/institutes/grid.4444.0",
"name": [
"INSERM, UMR 1170, 114 rue Edouard Vaillant, 94805, Villejuif, France",
"Universit\u00e9 Paris-Saclay, Gustave Roussy, Villejuif, France",
"Gustave Roussy, 94805, Villejuif, France",
"CNRS, GDR 3697, MicroNIT, Villejuif, France"
],
"type": "Organization"
},
"familyName": "Saavedra",
"givenName": "Erika",
"id": "sg:person.01120456102.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120456102.88"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP, H\u00f4pital St Antoine, Service d\u2019H\u00e9matologie clinique et de th\u00e9rapie cellulaire, F-75012, Paris, France",
"id": "http://www.grid.ac/institutes/grid.412370.3",
"name": [
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, GRC n\u00b07, Groupe de Recherche Clinique sur les My\u00e9loprolif\u00e9rations Aigu\u00ebs et Chroniques MYPAC, F-75012, Paris, France",
"AP-HP, H\u00f4pital St Antoine, Service d\u2019H\u00e9matologie clinique et de th\u00e9rapie cellulaire, F-75012, Paris, France"
],
"type": "Organization"
},
"familyName": "Tang",
"givenName": "Ruoping",
"id": "sg:person.010467152312.87",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010467152312.87"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Gu",
"givenName": "Yin",
"id": "sg:person.01017361200.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017361200.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Drug Safety Research & Development, Pfizer, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Drug Safety Research & Development, Pfizer, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Lappin",
"givenName": "Patrick",
"id": "sg:person.0742750321.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742750321.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Drug Safety Research & Development, Pfizer, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Drug Safety Research & Development, Pfizer, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Trajkovic",
"givenName": "Dusko",
"id": "sg:person.01140064074.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140064074.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Research & Development, Pfizer Worldwide Research & Development, San Francisco, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Oncology Research & Development, Pfizer Worldwide Research & Development, San Francisco, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Liu",
"givenName": "Shu-Hui",
"id": "sg:person.0724225111.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724225111.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Smeal",
"givenName": "Tod",
"id": "sg:person.0656507441.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656507441.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Fantin",
"givenName": "Valeria",
"id": "sg:person.01144565631.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144565631.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Facult\u00e9 de m\u00e9decine Paris-Sud, Kremlin-Bic\u00eatre, France",
"id": "http://www.grid.ac/institutes/grid.5842.b",
"name": [
"INSERM, UMR 1170, 114 rue Edouard Vaillant, 94805, Villejuif, France",
"Gustave Roussy, Universit\u00e9 Paris-Saclay, Service d\u2019H\u00e9matologie Clinique, Villejuif, France",
"Facult\u00e9 de m\u00e9decine Paris-Sud, Kremlin-Bic\u00eatre, France"
],
"type": "Organization"
},
"familyName": "De Botton",
"givenName": "Stephane",
"id": "sg:person.01123211416.80",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123211416.80"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP, H\u00f4pital St Antoine, Service d\u2019H\u00e9matologie clinique et de th\u00e9rapie cellulaire, F-75012, Paris, France",
"id": "http://www.grid.ac/institutes/grid.412370.3",
"name": [
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, GRC n\u00b07, Groupe de Recherche Clinique sur les My\u00e9loprolif\u00e9rations Aigu\u00ebs et Chroniques MYPAC, F-75012, Paris, France",
"AP-HP, H\u00f4pital St Antoine, Service d\u2019H\u00e9matologie clinique et de th\u00e9rapie cellulaire, F-75012, Paris, France"
],
"type": "Organization"
},
"familyName": "Legrand",
"givenName": "Ollivier",
"id": "sg:person.0752753564.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "AP-HP, H\u00f4pital Saint-Antoine, Service d\u2019h\u00e9matologie biologique, F-75012, Paris, France",
"id": "http://www.grid.ac/institutes/grid.412370.3",
"name": [
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France",
"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, GRC n\u00b07, Groupe de Recherche Clinique sur les My\u00e9loprolif\u00e9rations Aigu\u00ebs et Chroniques MYPAC, F-75012, Paris, France",
"AP-HP, H\u00f4pital Saint-Antoine, Service d\u2019h\u00e9matologie biologique, F-75012, Paris, France"
],
"type": "Organization"
},
"familyName": "Delhommeau",
"givenName": "Francois",
"id": "sg:person.0774547707.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774547707.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410513.2",
"name": [
"Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Pernasetti",
"givenName": "Flavia",
"id": "sg:person.014325521024.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014325521024.88"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "CNRS, GDR 3697, MicroNIT, Villejuif, France",
"id": "http://www.grid.ac/institutes/grid.4444.0",
"name": [
"INSERM, UMR 1170, 114 rue Edouard Vaillant, 94805, Villejuif, France",
"Universit\u00e9 Paris-Saclay, Gustave Roussy, Villejuif, France",
"Gustave Roussy, 94805, Villejuif, France",
"CNRS, GDR 3697, MicroNIT, Villejuif, France"
],
"type": "Organization"
},
"familyName": "Louache",
"givenName": "Fawzia",
"id": "sg:person.01343032313.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343032313.38"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/srep37827",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048060119",
"https://doi.org/10.1038/srep37827"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nm0797-730",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022333282",
"https://doi.org/10.1038/nm0797-730"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ni813",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022525407",
"https://doi.org/10.1038/ni813"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ni.1830",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008424982",
"https://doi.org/10.1038/ni.1830"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature11926",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034640189",
"https://doi.org/10.1038/nature11926"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/cddis.2012.137",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023982609",
"https://doi.org/10.1038/cddis.2012.137"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature11885",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038795491",
"https://doi.org/10.1038/nature11885"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrd3365",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037371960",
"https://doi.org/10.1038/nrd3365"
],
"type": "CreativeWork"
}
],
"datePublished": "2017-08-04",
"datePublishedReg": "2017-08-04",
"description": "The chemokine receptor CXCR4 mediates cell anchorage in the bone marrow (BM) microenvironment and is overexpressed in 25\u201330% of patients with acute myeloid leukemia (AML). Here we have shown that a new CXCR4 receptor antagonist IgG1 antibody (PF-06747143) binds strongly to AML cell lines and to AML primary cells inhibiting their chemotaxis in response to CXCL12. PF-06747143 also induced cytotoxicity in AML cells via Fc-effector function. To characterize the effects of PF-06747143 on leukemia progression, we used two different patient-derived xenograft (PDX) models: Patient 17CXCR4-low and P15CXCR4-high models, characterized by relatively low and high CXCR4 expression, respectively. Weekly administration of PF-06747143 to leukemic mice significantly reduced leukemia development in both models. Secondary transplantation of BM cells from PF-06747143-treated or IgG1 control-treated animals showed that leukemic progenitors were also targeted by PF-06747143. Administration of a single dose of PF-06747143 to PDX models induced rapid malignant cell mobilization into the peripheral blood (PB). These findings support evaluation of this antibody in AML therapy, with particular appeal to patients resistant to chemotherapy and to unfit patients, unable to tolerate intensive chemotherapy.",
"genre": "article",
"id": "sg:pub.10.1038/s41598-017-07848-8",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1045337",
"issn": [
"2045-2322"
],
"name": "Scientific Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "7"
}
],
"keywords": [
"acute myeloid leukemia",
"peripheral blood",
"myeloid leukemia",
"patient-derived xenograft models",
"primary acute myeloid leukemia",
"AML primary cells",
"high CXCR4 expression",
"control-treated animals",
"Fc effector functions",
"AML cell lines",
"chemokine receptor CXCR4",
"bone marrow microenvironment",
"unfit patients",
"intensive chemotherapy",
"weekly administration",
"AML therapy",
"CXCR4 expression",
"single dose",
"leukemic mice",
"PDX models",
"BM cells",
"AML cells",
"cell mobilization",
"receptor CXCR4",
"xenograft model",
"IgG1 antibodies",
"leukemic progenitors",
"leukemia progression",
"secondary transplantation",
"antibodies bind",
"patients",
"marrow microenvironment",
"leukemia development",
"chemotherapy",
"cell lines",
"leukemia",
"primary cells",
"administration",
"antibodies",
"cells",
"transplantation",
"CXCR4",
"therapy",
"CXCL12",
"mice",
"dose",
"blood",
"progression",
"microenvironment",
"cytotoxicity",
"chemotaxis",
"animals",
"expression",
"findings",
"mobilization",
"progenitors",
"response",
"evaluation",
"cell anchorage",
"effect",
"binds",
"function",
"anchorage",
"development",
"lines",
"model",
"particular appeal",
"appeal"
],
"name": "Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)",
"pagination": "7305",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1090990621"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/s41598-017-07848-8"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"28779088"
]
}
],
"sameAs": [
"https://doi.org/10.1038/s41598-017-07848-8",
"https://app.dimensions.ai/details/publication/pub.1090990621"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:18",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_736.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/s41598-017-07848-8"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-07848-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-07848-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-07848-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-07848-8'
This table displays all metadata directly associated to this object as RDF triples.
344 TRIPLES
22 PREDICATES
119 URIs
102 LITERALS
23 BLANK NODES